A2B adenosine receptor antagonists
US7521554B2 · kind B2 · utility
2Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2006 |
| Grant date | Apr 21, 2009 |
| Priority date | — |
| Expiry date | Mar 5, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are processes for the synthesis of novel compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.